How to use impedance-pH monitoring in clinical practice

Impedance-pH monitoring is an ambulatory test used to assess reflux by measuring both acid exposure and the movement of liquid or gas within the oesophagus. It can identify episodes that a conventional pH study may miss, particularly when symptoms continue without a clear fall in pH.

The test is most useful when the clinical picture remains uncertain, treatment has produced an incomplete response, or a procedure such as antireflux surgery is being considered. Results should be interpreted alongside symptom history, endoscopy, manometry and the patient’s treatment status rather than in isolation.

For clinicians in Australia, practical decisions may be shaped by referral pathways, public hospital waiting lists, private gastroenterology services and access outside major centres such as Sydney, Melbourne, Brisbane and Perth. Clear pre-test planning helps make a limited monitoring window clinically valuable.

Why reflux monitoring matters

Heartburn and regurgitation are common presentations, but symptoms alone do not prove gastro-oesophageal reflux disease. Chest discomfort, cough, throat clearing, hoarseness and upper abdominal pain may have several causes, and empiric proton pump inhibitor therapy can sometimes obscure the underlying pattern.

Ambulatory reflux monitoring can establish whether abnormal reflux is present, determine whether symptoms correlate with reflux events and help distinguish ongoing reflux from reflux hypersensitivity or functional symptoms. This distinction prevents repeated escalation of acid suppression when the mechanism is different.

The test may be performed off acid suppression when the diagnosis is not established, or on treatment when established reflux persists despite therapy. The question being asked should determine the protocol.

What impedance adds to pH testing

Standard pH monitoring detects acidification in the oesophagus. Multichannel intraluminal impedance detects changes in electrical resistance as swallowed material or refluxate passes through sensors. This allows the recording of acid, weakly acidic and non-acid reflux episodes, as well as the direction and approximate composition of the event.

Impedance can therefore be valuable for patients taking proton pump inhibitors, because reflux may continue while being less acidic. It can also document proximal extent and help assess whether symptoms occur soon after a reflux episode, although the findings still require cautious clinical interpretation.

A positive symptom association does not automatically prove causation. Diary accuracy, event timing, baseline symptom frequency and the possibility of chance association all affect the strength of the result.

Choosing appropriate patients

Consider impedance-pH monitoring when endoscopy is normal but reflux disease remains suspected, when symptoms persist after a properly taken PPI trial, or when atypical symptoms have not responded as expected. It can also support decision-making before antireflux surgery or endoscopic treatment.

Patients with alarm features need appropriate investigation rather than a monitoring study alone. Dysphagia, food impaction, gastrointestinal bleeding, iron-deficiency anaemia, unexplained weight loss or persistent vomiting may require endoscopy and other assessment first.

In Australia, a general practitioner may refer through a public hospital gastroenterology clinic or directly to a private specialist, depending on local arrangements and insurance coverage. Rural and regional patients may need careful coordination because catheter placement and specialist interpretation are often concentrated in larger centres.

Preparing and performing the study

Before testing, confirm whether the patient should stop or continue acid suppression. Medication instructions vary according to the diagnostic aim and must be supplied by the treating service. Patients should also understand how to record meals, posture, symptoms, sleep and medication use.

The catheter is passed through the nose and positioned with reference to the lower oesophageal sphincter, often using manometry or established anatomical landmarks. It connects to a portable recorder for approximately 24 hours, although longer wireless pH monitoring may be selected in some cases.

Patients can generally follow ordinary activities, eat usual meals and sleep normally unless the service provides different instructions. Everyday Australian habits, such as morning coffee, takeaway meals, late dinners, alcohol at a barbecue or vigorous exercise, may be relevant if they reflect the patient’s usual symptom triggers.

Reading the tracing

Key measures include acid exposure time, the number of reflux episodes, the duration of events and symptom association probability or symptom index. The normal range depends on the equipment, protocol and published reference criteria used by the laboratory.

Interpretation should assess whether the study was technically adequate and whether the patient followed the intended medication instructions. A high acid exposure time supports pathological acid reflux, while a normal acid burden with strong symptom association may indicate reflux hypersensitivity.

An elevated event count without abnormal acid exposure is not enough to diagnose disease. Swallowing, belching, coughing, movement artefact and poor diary timing can complicate automated analysis, so manual review remains important.

Applying findings to treatment

An abnormal off-treatment study supports a diagnosis of reflux and may justify optimising lifestyle measures and acid suppression, addressing adherence and considering further evaluation. Persistent symptoms with normal reflux burden should prompt review of functional gastrointestinal, respiratory, laryngeal, cardiac or musculoskeletal explanations where appropriate.

For patients already taking a PPI, impedance-pH monitoring can show whether symptoms correlate with weakly acidic or non-acid reflux. The response may involve timing the medication correctly, changing therapy selectively, treating reflux hypersensitivity or avoiding unnecessary escalation.

Surgical referral requires objective evidence and appropriate anatomical assessment, often including high-resolution manometry. A monitoring result should inform shared decision-making rather than act as an automatic indication for intervention.

A practical clinical checklist

Good preparation improves the usefulness of the recording and reduces avoidable repeat tests. Before scheduling, clarify the clinical question, medication status, previous endoscopy and whether manometry is required.

For clinicians reviewing educational material from the International Society for Diseases of the Esophagus, the archived congress resources and registration information provide context about the society’s scientific programme and professional education activities.

• Define whether the study is diagnostic or assessing symptoms on treatment.
• Give written instructions about PPI use, meals, sleep and symptom-button timing.
• Confirm alarm features have been investigated through the appropriate pathway.
• Review the raw tracing, diary entries and symptom association rather than relying only on the summary.
• Document how the result changes management, referral or reassurance.

Turning data into decisions

The most useful report answers a clinical question in plain language: Is reflux objectively abnormal, are symptoms temporally associated with reflux, and what should happen next? It should include technical limitations, medication status and any factors that reduce confidence in the result.

For an Australian patient, the plan may need to account for medication costs, private insurance, public waiting times, travel from regional areas and access to follow-up. A carefully interpreted impedance-pH study can reduce repeated consultations and avoid treatments that target the wrong mechanism.

In practice, start with the clinical question, match the testing protocol to that question, and interpret the tracing alongside the patient’s history rather than treating any single number as decisive.